-
AstraZeneca and Daiichi Sankyo sign $6.9bn cancer drug development deal
pharmaceutical-technology
April 11, 2019
AstraZeneca has entered a deal worth up to $6.9bn with Daiichi Sankyo to develop and commercialise cancer drug trastuzumab deruxtecan...
-
Researchers develop new vaccine to teach immune system to attack cancer
pharmaceutical-technology
April 11, 2019
Researchers develop new vaccine to teach immune system to attack cancer.
-
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund
pharmafile
April 11, 2019
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund.
-
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
drugs
April 11, 2019
BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ -- Seattle Genetics, Inc.
-
Immune cells fighting blood cancer visualized for the first time
worldpharmanews
April 10, 2019
When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease...
-
NICE recommends BMS’ Opdivo-Yervoy combination for RCC
pharmaceutical-technology
April 09, 2019
Bristol-Myers Squibb (BMS) has announced that the National Institute of Health and Care Excellence (NICE) has recommends Opdivo (nivolumab) and...
-
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
b3cnewswire
April 09, 2019
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
-
XenTech SAS Partners with Gustave Roussy for Cancer
contractpharma
April 03, 2019
For the development of a collection of tumor explant models from patients who developed acquired resistance to targeted therapies following initial responses.
-
Triphase Accelerator Initiates Phase I Trial of TRPH-222
contractpharma
April 02, 2019
Next-Gen Antibody-Drug Conjugate developed using Catalent’s SMARTag ADC Technology
-
New glioblastoma cancer vaccine shows promise in phase 1b clinical trial
europeanpharmaceuticalreview
April 02, 2019
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial…